documentcv

Curriculum Vitae

Robert W. Steiner, M.D.

PERSONAL DATA

Business Address: Clinical Professor of MedicineDirector, Transplant NephrologyMedical Director, Kidney & Pancreas TransplantationMedical Director, Lifesharing of San DiegoUCSD Center for Transplantation200 West Arbor Drive, MC 8409San Diego, CA 92103-8409(619) 471-0748 Office(619) 471-0754 Fax

Born: February 28, 1945, Milwaukee, Wisconsin

EDUCATION AND TRAINING

1959-1963 Graduated - Richwood Community High School, Peoria, Illinois

1963-1967 Dartmouth College, Hanover, New Hampshire - B.A.

1967-1968 Queen's College, Oxford, England

1968-1972 Harvard Medical School - M.D.

1972-1973 Intern, Cambridge Hospital, Boston, MA

1973-1974 Assistant Resident in Medicine, Massachusetts General Hospital, Boston, MA

1974-1975 Renal Fellow, Massachusetts General Hospital, Boston, MA

1975 Certified American Board of Internal Medicine (ABIM)

1975-1976 Emergency Room Physician, Harrington Hospital, Southbridge, MA

1976-1978 Renal Fellow (Research), Veterans Administration Hospital and University of California, San Diego, Medical Center, San Diego, CA with Roland Blantz, M.D.

1978 Certified in subspecialty of Nephrology (ABIM)

CV – Steiner, Robert of 22 4/10/2023

1978 Assistant Professor of Medicine, Certified in subspecialty of Nephrology, (ABIM) University of California, San Diego, San Diego, CA

1978-present Attending Physician, Division of NephrologyUniversity of California, San Diego, School of Medicine, San Diego, CA

1978-1979 Assistant Adjunct Professor of MedicineUniversity of California, San Diego, San Diego, CA

1980-1985 Assistant Clinical Professor of MedicineUniversity of California, San Diego, San Diego, CA

1985-1990 Associate Clinical Professor of MedicineUniversity of California, San Diego, San Diego, CA

1991-present Clinical Professor of MedicineUniversity of California, San Diego, San Diego, CA

Robert W. Steiner, MDRevised March 6, 2007

2

AWARDS AND HONORS:Phi Beta Kappa, 1966.Departmental Prize in Philosophy, 1967 (Dartmouth College).Graduated Summa Cum Laude, 1967 (Dartmouth College).Fullbright Scholarship, Queen's College, Oxford, England (in Philosophy) 1967-

1968.Career Development Award (R and E), Veterans' Administration Hospital (San

Diego, CA): Micro Puncture Investigation of Goldblatt Hypertension (declined) 1979.

UCSD Medical Center Special Patient Care Incentive Award, 1981-1982.UCSD Medical Center Graduating House Staff Teaching Award for Excellence in the

Education of Medical House Staff - Honorable Mention, 1996.UCSD Medical Center Graduating House Staff Teaching Award for Excellence in the

Education of Medical Residents - Honorable Mention, 2001.Nominated for Healthcare Foundation of New Jersey’s Humanism Award, 2001.UCSD Medical Center Graduating House Staff Teaching Award for Excellence in the

Education of Medical Residents - Honorable Mention, 2002.Departmental Nominee for Initial Membership, Academy of Clinical Scholars, UCSD

SOM, 2002.

UCSD System wide Faculty Award for Excellence in Clinical Care, 2003.Peer-Voted One of “Best Doctors in San Diego,” San Diego Magazine, 9-2005Peer-Voted One of “Best Doctors in San Diego,” San Diego Magazine, 9-2006

POSITIONS:Diener, Peter Bent Brigham Hospital, Boston MA, 1968-1970.Proctor, Harvard College, Boston, MA, 1969-1972.Associate Director, Division of Emergency Medical Services, University of

California, San Diego, Medical Center, San Diego, CA, 1978-1979.Consulting Nephrologist, Rees Stealy/Sharp Rees Stealy Medical Group, San Diego,

CA, 1980-1990.Associate Director of Dialysis, University of California, San Diego, Medical Center,

San Diego, CA, 1980-1989.

Director, Continuous Ambulatory Peritoneal Dialysis Program, University of California, San

Diego, Medical Center, San Diego, CA, 1980 to present.Head, Nephrology Teaching Service, Mercy Hospital and Medical Center, San

Diego, CA, 1981-1985.Reviewer (past and/or present), Journal of the American Medical Association, Archives of

Internal Medicine, Journal of Cardiac Rehabilitation, American Journal of Kidney

Diseases, Arthritis & Rheumatism, Journal of Clinical Investigation, Psychosomatic

Medicine, and Journal of the American Society of Transplantation.Renal Conference Coordinator, University of California, San Diego, Division of

Nephrology, San


3

Diego, CA, 1982-1999.Fellows Conference Coordinator, University of California, San Diego, Division of

Nephrology, San Diego, CA, 1984-1989.

Attending Physician, Postoperative Renal Transplant Outpatient Clinic, University of California,

San Diego, Medical Center, San Diego, CA, 1982 to present.Director of Transplant Nephrology, University of California, San Diego, Medical

Center, San Diego, CA, 1990 to present.

Attending Staff, Mercy Hospital and Medical Center, Sharp Memorial Hospital, San Diego, CA,

1979-1995.Chairman, Task Force on Nutrition in Peritoneal Dialysis Patients, Baxter Peritoneal

Dialysis Division, Chicago, IL 1995-1996.Medical Director, Lifesharing Community Organ & Tissue Donation) 1996 to present,

3465 Camnio Del Rio South, Suite #410, San Diego, CA 92108

COMMITTEES:Co-chairman, House Staff Association, Cambridge Hospital, Cambridge, MA, 1972-

1973.Emergency Medicine Concentration Area Committee, University of California, San

Diego, Medical Center, San Diego, CA 1978-1979.

Risk Management Committee, University of California, San Diego, Medical Center, San Diego, CA, 1978-1982, 1985-1987, 1988-1989.

Student Advisor, University of California, San Diego, School of Medicine, 1982-1988.

Student Affairs Committee, University of California, San Diego, School of Medicine, 1982-1983.

Student Affairs Committee Chairman, University of California, School of Medicine, 1983-1984.

Dialysis and Transplantation Committee, University of California, San Diego, Medical Center,

San Diego, CA, 1980 to present.Chairman, Transplantation Committee, University of California, San Diego, Medical

Center, San Diego,CA, 1983-1984, 1985-1988.

Disaster Preparedness Committee, University of California, San Diego, Medical Center, San

Diego,CA, 1984-1985.Utilization Review Committee, University of California, San Diego, Medical Center,

San Diego, CA, 1984-1987.Clinical Competence in Nephrology, University of California, San Diego,

School of Medicine, San Diego, CA, 1986.National Kidney Foundation (Southern California): Scientific Advisory Committee,

Vice Chairman, 1987-1989, and Member, Regional Board of Directors, 1990.


4

Marketing Task Force, University of California, San Diego, Medical Center, San Diego,

CA, 1990.Committee for Standardizing CAP (Committee on Academic Performance) Criteria,

Department of Medicine, University of California, San Diego, School of Medicine, San

Diego, CA, 1991-1996.Medical Advisory Committee, OTAC (Organ and Tissue Acquisition Center of

Southern California) 1992 to present.Nephrology Quality Assurance Committee, Chairman 1992-1993.Department of Medicine, Quality Assurance Committee, 1992-1993.Critical Path Committee/Renal Transplantation, University of California, San Diego,

Medical Center, San Diego, CA, 1992-1993.

Chairman, Transplantation Services Committee, University of California, San Diego, Medical

Center, San Diego, CA, 1993-1995.Member, Transplantation Services Committee, University of California, San Diego,

Medical Center, San Diego, CA, 1993 to present.

Member, Risk Management Committee, University of California, San Diego, Medical Center,

San Diego, CA, 2001 to present.Patient Care & Education Committee, American Society of Transplantation, 2001 to

2004Member, American Society of Transplantation Awards and Grants Committee, 2005 to present.

HONORS, POSITIONS, AND INVITED LECTURESPreceptor, first year UCSD student N.I.H. summer research projects, 1991 to present.Preceptor, UCSD student Independent Study research projects, 1993 to present Shadi Imani (First year N.I.H. summer grant and independent study project student) awarded

class prize for best independent research, UCSD School of Medicine graduation 1999.Lecturer, “How to perform a medical history and physical examination,” to students beginning

third year Medicine rotation, 2002-2003.


5

Clinical Drug Investigations and Trials:

Principal Site Investigator:

Pentoxiphylline as prophylaxis for OKT3 induced cytokine release, 1994.

Thymoglobulin for acute renal transplant rejection, 1996-1997.

IVIG for highly sensitized patients awaiting renal transplantation, 1998 to present.

Sirolimus/prednisone immunosuppression after renal transplantation, 1998 to present.

Peripheral vein administration of thymoglobulin for induction therapy in adult renal allograft recipients, 1998 to present.

A randomized, open-label study of cyclosporine elimination in renal allograft recipients treated with Sirolimus, cyclosporine, and corticosteroids in the early postoperative period, 1998 - 2001.

FK506 treatment for chronic renal transplant dysfunction in patients receiving cyclosporine immunosuppression, 1999 to present.

Analysis of long term effects of immunosuppression and other clinical parameters of renal transplant recipients, 2000.

An open label study to evaluate graft function in de novo renal allograft recipients treated with either a “reduced dose” or a “standard dose” of cyclosporine in combination with rapamune (Sirolimus) and corticosteroids, 2000-2004.

Rapamune and reduced dose cyclosporine or reduced dose FK506 for chronic renal allograft dysfunction. (Wyeth, 2000-2003)

A randomized, open label preference study of Gengraf compared to Neoral in stable solid organ transplant subjects. (Abbott, 2002)

Rapamune Outcomes Assessment Registry (ROAR). (Wyeth, 2000 -2001) 7.5% Iocodextrin peritoneal dialysis solution: a non-absorbable experimental agent to increase transperitoneal ultrafiltration. (Baxter Pharmaceuticals, 2003)

Clinical aspects of C2 ACU profiling to assess Neoral exposure in post op and long term kidney transplant patients. (Novartis, 2004-2005)

A prospective,randomized, open label, twenty-six week study of the efficacy and safety of converting kidney and liver transplant recipients with Tacrolimus-associated abnormal glucose metabolism to Neoral with C2 monitoring. (Novartis US06, 2004-2005)


6

Persistence of immunosuppression in normal subjects taking sirolimus, tacacrolimus or cyclosporine. (Wyeth, 2006-2007)

A phase 4 open-label multicenter trial evaluating the efficacy of Fosrenol compared to existing therapy in adults with end-stage renal disease treated for hyperphosphatemia(short title "Fosrenol for Dialysis Hyperphosphatemia"). (Shire Pharmaceuticals)

A three-month, open-label, two cohort study to investigate the safety and tolerability of Myfortic® in combination with Neoral® or Tacrolimus in renal transplant recipients with GI intolerance (My TIME). (Novartis Pharmaceuticals)

Neoral conversion in renal transplant recipients who develop glucose intolerance when receiving Trerolimus (Norvartis Pharmaceuticals)

Once a day Neoral in chronic kidney transplant recipients. (Novartis, pending).

Persistence of immunosuppression in normal subjects after discontinuation of a short course of cyclosporine, sirolimus, or tacacrolimus. (Wyeth, pending)


7

Publications

1. Tucker, B.J., Steiner, R.W., Gushwa, L., Blantz, R.C. Studies in the tubuloglomerular feedback system in the rat. Mechanism of the reduction in filtration rate with Bezolamide. J Clin Invest 62:993-2004, 1978.

2. Steiner, R.W., Blantz, R.C. Clinical use of diuretics in non-edematous states. Medical Times 107, (12):5s-13s, 1979.

3. Steiner, R.W., Coggins, C., Carbalho, A.C.A. Bleeding time in uremia: A useful test to assess clinical bleeding. Am J Hematol 7 (2):107-118, 1979.

4. Steiner, R.W., Blantz, R.C. Acute reversal by Saralasin of multiple intrarenal effects of angiotensin II. Am J Physiol 127 (5):F386-F391, 1979.

5. Steiner, R.W., Tucker, B.J., Blantz, R.C. Glomerular hemodynamics in rats with chronic sodium depletion. J Clin Invest 64:503-512, 1979.

6. Blantz, R.C., Steiner, R.W., Tucker, B.J. Studies in the efferent limb of the tubuloglomerular feedback system. Federation Proceedings 40:104-108, 1981.

7. Bailey, C.C., Steiner, R.W. Renal acidification defect in diabetic ketoacidosis. Ann Int Med 92:(2)263, 1980 (letter).

8. Steiner, R.W., Manoguerro, A.S. Severe methemoglobinemia from butyl nitrate ingestion. Ann Int Med 92:570, 1980 (letter).

9. Manoguerra, A.S., Steiner, R.W. Prolonged neuromuscular blockade after administration of physostigmine and succinylcholine. Clin Toxicol 19,(7), 803-805, 1981.

10. Steiner, R.W., Tucker, B.L.J., Blantz R.C. Glomerular hemodynamics in moderate Goldblatt hypertension in the rat. Hypertension IV:51-57, 1982.

11. Steiner, R.W. Low fractional excretion of sodium in myoglobinuric renal failure. Arch Int Med, 142:5:1216-1217, 1982.

12. Steiner, R.W. Clinical observations on the pathogenesis of peritoneal dialysate eosinophilia. Peritoneal Dialysis Bulletin, 2:7-10, 118-119, 1982.

13. Steiner, R.W. Adverse effects of intraperitoneal methylene blue. Peritoneal Dialysis Bulletin 3:1:43, 1983 (letter).

14. Steiner, R.W., Kipper, S., Savoia, M.C., Witztum, K. Identification of peritoneal dialysis catheter associated infection by scanning with III indium labeled leukocytes. Ann Int Med 99:1:44-45, 1983.

15. Steiner, R.W. Characteristics of the hematocrit response to continuous ambulatory peritoneal dialysis. Arch Int Med 144:728-732, 1984.


8

16. Kipper, S.L., Steiner, R.W., Witztum, K.G., Basarab, R.M., Kipper, M.S., Halpern, S.E., Ashburn, W.L. Indium-III leukocyte scintigraphy for the detection of infections associated with peritoneal dialysis catheters. Radiology 151:491-494, 1984.

17. Steiner, R.W., Kipper, S.L., Witztum, K., Ashburn, W. Indium-III leukocyte scanning for catheter infections in peritoneal dialysis patients. Perspectives in Peritoneal Dialysis 33-35, 1984.

18. Steiner, R.W. Interpreting the FENa. Am J Med 77:699-702, 1984.

19. Fredericks, M.J., Dworkin, R., Ward, D.M., Steiner, R.W. Antibiotic-induced acute renal failure associated with an elevated serum lactate dehydrogenase level of renal origin. West J Med 144:6:743-744, 1986.

20. Steiner, R.W., Omachi, A.S. A Bartter's like syndrome from capreomycin and a similar gentamicin tubulopathy. Am J Kidney Dis VII:3:245-249, 1986.

21. Halasz, N.A., Gamboa, E.Z., Ward, D.M., Steiner, R.W., Bronsther, O.L. Kidney transplantation in the cyclosporine era. Arch Surg 122:1001-1004, 1987.

22. Steiner, R.W. Four cases of unusual events in CAPD patients. Peritoneal Dialysis Bulletin 7:2:107, 1987.

23. Steiner, R.W. Feasibility of in-hospital long-dwell peritoneal dialysis. Peritoneal Dialysis International 8:4:288, 1988 (letter).

24. Steiner, R.W. Continuous equilibration peritoneal dialysis in acute renal failure. (editorial) Peritoneal Dialysis International 9:1:5-7, 1989.

25. Steiner, R.W., Halasz, N.A. Abdominal catastrophes and other unusual events in CAPD patients. Am J Kidney Dis 15:1:1-7, 1991.

26. McDonald, B.R., Steiner, R.W. Rapid infusion of HCl during citrate dialysis to counteract alkalosis. Clin Nephrol 33 (5):255-256, 1990 (letter).

27. Steiner, R.W., The electrolytes in hyponatremia. Am J Kidney Dis 19:6, 617, June, 1992 (letter).

28. Steiner, R.W., Ziegler, M., Halasz, N.A., Catherwood, B.D., Manolagas, S., and Deftos, L.J. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 56:843-846, 1993.

29. Steiner, R.W. Elevated levels of tumor necrosis factor in the nephrotic syndrome in humans. Am J Kidney Dis 22:622, 1993 (letter).

30. Steiner, R.W. Another method for correcting metabolic alkalosis. Am J Kidney Dis 26:3, 000-000, 1995 (letter).


9

31. Weingarten, K.E., D’Agostino, H.B., Dunn, J., Steiner, R.W. Obturator herniation of the ureter in a renal transplant recipient causing hydronephrosis: Perioperative percutaneous management. Journal of Vascular and Interventional Radiology 7:6, 939-941, 1996.

32. Nguyen, T., Steiner, R.W. A trial of oral magnesium supplementation in renal transplant recipients receiving cyclosporine. Transplantation Proceedings 30, 4317-4319, 1998.

33. Imani, S., Jusko, W., Steiner, R.W. Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers. Pediatric Transplantation. 3:2, 126-30, 1999.

34. Gaber, O.A., First, R.M., Steiner, R.W., et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes in renal transplantation. Transplantation 66:1, 29-37, 1998.

35. Steiner, R.W. Physiology of beer or non-beer potomania. Am J of Kidney Dis 32:6. 1123, 1998 (letter).

36. Steiner, R.W., Gert, B. Ethical selection of living kidney donors. Am J Kidney Dis 36:4, 677- 686, 2000.

37. Steiner, R.W., Gert, B. A technique for presenting risk and outcome data to potential living renal transplant donors. Transplantation 71:8, 1056-1057, 2001.

38. Steiner, R.W. Is consent of an uninformed organ donor valid? Am J of Kidney Dis 32:6. 1141, 2001 (Letter to Editor).

39 Steiner, R.W., Chanchairujira, T., Leyden, S., Proteinuria in “normal” cadaver kidney donors.

transplantation , Vol. 74, 1788-1803, No. 12, December 27,2002.

40. Jeng, S, Chanchairujira, T, Jusko, W, Steiner, R.W. Prednisone metabolism in recipients of

kidney or liver transplants and in lung recipients receiving ketoconazole. Transplantation, Vol. 75, 792-795, No. 6, March 27,2003.

41. Steiner, R.W. Noncompliance with medications in organ transplant recipients. Medscape

(internet journal), 10-2004.

42. Steiner, R.W. Risk appreciation for living kidney donors – do we need another subspecialty?

Am J Trans 2004; 4: 694-697.

43. Jordan C, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey


10

D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH OG02 trial. J Am Soc Nephrol 2004; 15: 3256-3262.

46. Steiner, R.W. Consequences of selling a kidney in India. JAMA, 2004; 289:1 (Letter to

Editor).

44. Steiner, R.W. How should we ethically select living kidney donors when they all are at risk?

2005; 15:2 (Letter to Editor).

45. Steiner, R.W. In defense of steroids. Am J Trans, 2005; 15: 56 (Letter to Editor).


11

Abstracts

1. Steiner, R.W., Firgon, R., Gushwa, L.D., Stone, R., Blantz, R.C. Studies on the pathogenesis of renovascular hypertension (RVH). Presented at the 9th Annual Meeting, American Society of Nephrology, Washington, D.C. 1976. Kidney International 10, (6):535, 1976.

2. Tucker, B.J., Steiner, R.W., Gushwa, L., Blantz, R.C. Tubuloglomerular feedback (TGF) mediated reduction in nephron filtration rate (sngfr) with Benzolamide (B). Presented at the 10th Annual Meeting of the American Society of Nephrology, Washington, D.C. 1977. Kidney International 12, (6):575, 1977.

3. Steiner, R.W., Gifford, J., Gushwa, L., Tucker, B., Blantz, R.C. Micropuncture study of the unclipped kidney in Goldblatt hypertension. Presented at the Annual Meeting, Western Society for Clinical Research, Carmel, California, 1977, and at the Annual Meeting, International Society of Nephrology, Montreal, 1978.

4. Steiner, R.W., Blantz, R.C. Nonuniform antagonism by Saralasin of multiple intrarenal effects of Angiotensin II. Presented at the 11th Annual Meeting, American Society of Nephrology, New Orleans, LA, 1978. Kidney International 14:703, 1978.

5. Kipper, S., Steiner, R.W., Basarab, R., Kipper, M., Witztum, K., Halpern, S., Ashburn, W. Indium-111 leukocyte scintigraphy for detection of peritoneal catheter tunnel infections. Presented at the Society of Nuclear Medicine 30th Annual Meeting., St. Louis, 1983.

6. Ziegler, M., Woodson., L., Steiner, R.W. Abnormal renal catechol production in long-standing renal transplant recipients (RTR). Submitted to the 17th Annual Meeting of American Society of Nephrology, Washington, D.C., 1984. Kidney International 27:203, 1985.

7. Steiner, R.W., Ziegler, M., Halasz, N., Deftos, L. Determinants of phosphate (P) wasting in renal transplant recipients (RTR). Poster presentation at the 17th Annual Meeting of American Society of Nephrology, Washington, D.C., 1984. Kidney International 27:349, 1985.

8. Steiner, R.W., Catherwood, B., Manolagas, S., Ziegler, M., Halasz, N., Deftos, L. Plasma bone carboxy glutamate-containing protein (BGP), a measure of bone turnover, is elevated in renal transplant recipients. Poster presentation at the 4th Annual Meeting of the American Society of Transplant Physicians, Chicago, Il, 1985.

9. Steiner, R.W., Ziegler, M., Catherwood, B., Halasz, N., Deftos, L. High carboxy (CPTH) and markedly lower amino terminal (NPTH) parathormone levels in renal transplant (RT) patients (RTP's) respond to oral calcium therapy (CT) with reduction in phosphate wasting (PW). Poster presentation at the 20th Annual Meeting of the American Society of Nephrology, Washington, D.C., 1987. Kidney International 33:1:452, 1988.


12

10. Steiner, R.W., Manolagas, S., Ziegler, M., Deftos, L. Lack of responsiveness of 1-25 (OH)2 cholecalciferol (1-25 D3) to serum phosphate (PO4) or parathyroid hormone

(PTH) in renal transplant recipients (RTR's). Presented at the 19th Annual Scientific Meeting of the National Kidney Foundation, Washington, D.C., 1989. (Poster)

11. Steiner, R.W., Kim, R, Sartoris, D. Determinants of bone mineral density (BMD) in renal transplant patients (RTP's). Presented at the 23rd Annual Meeting, The American Society of Nephrology, Washington, D.C. 1990. JASN 1:4:771, 1990. (Poster)

12. Steiner, R.W. OKT3 Induction therapy offers no advantage in highly sensitized renal transplant recipients (RTR's). Submitted to the 24th Annual Meeting of the American Society of Nephrology, Baltimore, MD, 1991. JASN 2:3:818, 1991.

13. Steiner, R.W., Dunn, J., Halasz, N. Determinants of response to OKT3 in renal transplant recipients (RTR's). Submitted to the 24th Annual Meeting of the American Society of Nephrology, Baltimore, MD, 1991. JASN 2:3:818, 1991.

14. Steiner, R.W., Blakely, P., Friedman, L., Kaiser, J. Reproducibility and relationship of PET data to clinical parameters in CAPD patients. Poster presentation at the 13th Annual Conference on Peritoneal Dialysis, San Diego, CA 1993.

15. Vincenti, F., Danovich, G.M., Gaston, R., Neylan, J., Steiner, R.W. Pentoxiphylline does not prevent cytokine induced first dose reactions following therapy of acute renal transplant rejection with OKT3. Presented at the 14th Annual Scientific Meeting, American Society of Transplant Physicians, Chicago, IL, May 14-16, 1995.

16. Li, S., Heisterkamp, S., Hart, M., Masteller, M., Dunn, J., Cestero, R., Steiner, R.W. High Incidence of Severe Early Rejection in Living Unrelated Renal Transplantation. Presented at the 14th Annual Scientific Meeting, American Society of Transplant Physicians, Chicago, IL, May 14-16, 1995. (Poster)

17. Steiner, R.W., Nguyen, T., Ziegler, M. Oral Magnesium (Mg++) Repletion in Renal Transplant Patients (RTP's) Taking Cyclosporine (CSA). Presented at the 28th Annual Meeting of American Society of Nephrology, San Diego, 1995. JASN 6:3, No. 1122, 1995. (Poster)

18. Steiner, R.W., Machado, L. Acute Early Renal Transplant Rejection May Not Progressively Worsen Chronic Transplant Function. Submitted to 28th Annual Meeting of American Society of Nephrology, San Diego, 1995. In: JASN 6:3, No. 1102, 1995. (Poster)

19. Steiner, R.W., Chatfield, E., Ward, D., Mehta, R. Cyclosporine Requirement is Reduced and Creatinine Increases after Conversion from Sandimune to Neoral, Except in Patients Taking Diltiazem or Verapamil. Presented to 15th Annual Scientific Meeting of American Society of Transplant Physicians, Chicago, 1997. (Poster)


13

20. Imani, S., Jusko, W., Steiner, R.W. Prednisone Area Under the Curve is Increased by Diltiazem With Effects on Circulating T Cell Markers. Presented to 15th Annual Scientific Meeting of American Society of Transplant Physicians, Chicago, 1997. (Poster)

21. Steiner, R. W., Michel, D. M. Cyclosporine Area Under the Curve Measurements Do Not Predict Biopsy Proven CSA Nephrotoxicity in Renal Transplant Recipients. Presented at the 30th Annual Meeting & Scientific Exposition of the American Society of Nephrology, San Antonio, 1997. (Poster)

22. Michel, D.M., Cestero, R., Steiner, R.W. The Effect of Early Dose Finding During Cyclosporine Induction on Early Renal Transplant Nephrotoxicity and Rejection. Presented at the 31st Annual Meeting & Scientific Exposition of the American Society of Nephrology, Philadelphia, 1998.

23. Pham, T.T., Jusko, W.J., Steiner, R.W. Daily Prednisone Exposure (as Prednisolone AUC) Can Be Calculated from a Single Post Dose Measurement in Normal Subjects and in Transplant Recipients (Poster). Am Soc Trans, Chicago, 2000.

24. Tabibzadeh, S., Jusko, W, Steiner, R.W. Diltiazem (D) increases Prednisone (P) effects on Lymphocytes (L) by slowing metabolism Diltiazem effects of single vs multiple doses. 33rd Annual Meeting of American Nephrology Society, October, 2000.

25. Leyden, S, Steiner R. W. The Use of Measured Creatinine Clearance to Evaluate the Suitability of Cadaveric Kidneys for Transplantation. Supported by grant from National Association of Transplant Coordinators, presented at annual meeting, 2001.

26. Steiner, R.W., Norman, D., Cohen, D. A prospective multicenter study demonstrates safety and efficacy of peripheral vein administration of thymoglobulin for induction immunosuppression (Poster). Am Soc Trans, Chicago, May 2001.

27. Jeng, S, Pham, T, Tabibzadeh, S, Chanchairujira, T, Jusko, W, Steiner, R.W. Prednisone metabolism is slower in solid organ transplant recipients than in normals and is proportional to Cyclosporine Metabolism (Poster). Am Soc Trans, 2000, Chicago, May 2001.

28. Steiner, R.W., Leyden, S. Significant proteinuria occurs terminally in “normal” cadaver kidney donors without apparent renal disease (Poster) American Society of Transplantation annual meetings, 2001, Chicago, May 2001.

29. Leyden, S., Gates, S., Shragg, P., Steiner R.W. A Profile of Serum Sodium Concentration, Polyuria, Measurements of Renal Function, and Other Medical Parameters In Cadaver Donors and Their Effects on Post Transplant Renal Function (Poster) Am Soc Trans annual meetings, Chicago, 2001.


14

30. Khushu, S., Shragg, P., Savage, B., Pierce, L, Steiner, R.W. Patterns and Determinants of Post Transplant Obesity in Renal Transplant Recipients. (Am Soc Neph Poster). J.A.S.N 13: 375A, 2002

31. Khushu, S., Pierce, L., Shragg, P., Savage, B., Steiner, R.W. A Protocol for the Safe Discontinuation of Mycophenolate Mofetil in Renal Transplant Recipients. (Am Soc Neph Poster). J.A.S.N. 13: 368A, 2002.

32. Batarse, R.R., Leyden, S., Shragg, P., Steiner, R.W. Creatinine production rate in deceased kidney donors: a crucial yet unmeasured variable. (Poster) National Kidney Foundation Meeting, Chicago, IL, April, 2006

33. Rizos, D., Leyden, S., Shragg, P., Steiner, R.R. Identifying quality in extended criteria donor kidneys by using measured creatinine clearance. (Poster) World Transplant Congress, Boston, MA, July, 2006.

34. Steiner, R.W., Frederci, C. Estimating risk for “high risk kidney donors. (Poster) 3rd

International conference, Living donor Abdominal Organ Transplantation: State of the Art, Sardinia, Italy, June 2006.

35. Steiner, R.W., Frederci, C. Testing for “clear thinking” in living kidney donors. (Oral presentation) 3rd International conference, Living donor Abdominal Organ Transplantation: State of the Art, Sardinia, Italy, June 2006

36. Batarse, R.R., Pierce, L., Shragg, P., Steiner, R.W. Does QD sirolimus cause variable dxciurnal neural exposure? World Transplant Congress, Boston, MA, July, 2006.

37. Batarse, R.R., Jusko W, Hart ME, Pierce L, Shragg P, Steiner, R.W. Cyclosporine (neoral) and prednisone metabolism are correlated in renal transplant recipients (RTR’s). World Transplant Congress, Boston, MA, July, 2006.


15

Invited Articles and Chapters

1. Steiner, R.W. Exercise and the kidney. J Card Rehab 3:9:581-582, 1983. Invited article.

2. Steiner, R.W. Peritoneal Dialysate Eosinophilia. In: Dialysis Therapy, eds. Allen Nissenson, M.D. Richard Fine, M.D., 1986, Hanley & Belfus, Inc. pp 129-130.

3. Steiner, R.W. Abdominal Catastrophes, Peritoneal Eosinophilia, and Other Unusual Abdominal Events in Peritoneal Dialysis Patients. In: Dialysis Therapy, 2nd edition, eds. Nissenson, AR and Fine, RN, 1993, Hanley & Belfus, Inc. PP. 181-185. Book Chapter.

4. Steiner, R.W. Quality Assurance in Renal Transplantation. In: Quality Assurance in Dialysis, eds. Thuma, R.S. and Henderson L.W. 36:11:167-190, 1994.

5. Steiner, R.W. Common misperceptions in diagnosing and managing renal problems. Hospital Medicine, September 15-21, 1996.

6. Steiner, R.W. Quality Assurance in Renal Transplantation. In: Quality Assurance in Dialysis, Second Edition. Eds, Thung, R.S. and Henderson, L.W., 1999.

7. Steiner, R.W. Abdominal Catastrophes, Peritoneal Eosinophilia, and Other Unusual Abdominal Events in Peritoneal Dialysis Patients. Dialysis Therapy, Third Edition. Eds. Nissenson AR, Fine R. Pp 263-268, 2001.

8. Steiner, R.W., Bennett, W., Gert B. Ethical Approaches to Living Kidney Donor Education and Acceptance. In: Educating, Evaluating, and Accepting Living Kidney Donors. Steiner, R editor, Kluwer Academic Publishers, Summer 2003.

9. Steiner, R.W., Danovitch, G. The Medical Evaluation and the Risk of End Stage Renal Disease for Living Kidney Donors. In: Educating, Evaluating, and Accepting Living Kidney Donors, Steiner, R., editor, Kluwer Academic Publishers, Summer 2003.

10. Steiner, R.W., Frederici, C. The Education and Counseling Process for Living Kidney Donors; In: Educating, Evaluating, and Accepting Living Kidney Donors, Steiner, R.W., Editor, Kluwer Academic Publishers, Summer 2003.

11. Steiner, R.W. (editor), Educating, Evaluating, and Accepting Living Kidney Donors. Klewer Academic Publishers, Dordrecht, 2004.

12. Steiner, R.W., Frederici C.A., Batarse R.R., Gert B. Teaching and Testing the Knowledge and Thinking of Living Organ Donors. In: Living Donor Organ Transplantation.. Gruessner R.W.G and Benedetti E, Editors, The McGraw-Hill Companies, New Your, NY. (In press).

Publication


16

1. Steiner, R.W., (Editor) Educating, evaluating, and selecting living kidney donors. Kluwer Academic Publishers, Dordrecht, 2004.


17

Selected Presentations and Lectures

1. Eosinophilic Peritonitis (and symposium organizer). Peritoneal Dialysis Symposium, sponsored by the University of California, San Diego, School of Medicine, December 4, 1981, San Diego, CA.

2. The Internist and the Donor Crisis. 14th Annual Topics in Internal Medicine, sponsored by the Department of Medicine, University of California, San Diego, February 20, 1989, San Diego, CA.

3. Transplant Options in Elderly and High Risk Patients. 31st Annual Scientific Symposium on Kidney Disease, sponsored by the National Kidney Foundation of Southern California, October 12, 1991, La Jolla, CA.

4. Abdominal Catastrophes in CAPD patients. 11th Annual Advanced Nephrology Course: Nephrology for the consultant, sponsored by the University of California, School of Medicine, January, 1992.

5. Moderator, Section on Renal Transplantation. 11th Annual Advanced Nephrology Course: Nephrology for the Consultant, sponsored by the University of California, School of Medicine, January, 1992.

6. A Strategy for Cyclosporine Dosing. UCSD community Physicians Renal Transplant Education Dinner, June 1992.

7. Oral Presentation Session on Clinical Immunosuppression, Co-chairman, 12th Annual Meeting, American Society of Transplant Physicians, Houston, TX, 1993.


9. Cardiac Testing in the Potential Renal Transplant Recipient. 12th Annual Advanced Nephrology: Nephrology for the Consultant, sponsored by the University of California, San Diego, School of Medicine, January 28-30, 1993, San Diego, CA.

10. Adequacy of Hemodialysis and Peritoneal Dialysis. Options in Renal Therapy Meeting sponsored by the National Kidney Foundation of Georgia, Atlanta, Georgia, October 1993.

11. Kidney Transplantation, an Update. Topics and Advances in Internal Medicine sponsored by the University of California Department of Medicine/School of Medicine in San Diego, February 24, 1994.



18

13. Peritoneal Dialysis: Are Adequacy Studies Critical? Nephrology, Dialysis, Transplantation '94, Sixth Annual Conference for Nephrologists and Nephrology Nurses and Allied Health Professionals in Monterey, California, May 6 and 7, 1994.

14. Cyclosporine Induction for Kidney Transplantation at UCSD Medical Center. Grand Rounds of the Loma Linda University Medical Center Transplantation Institute, Loma Linda, California, July 29, 1994.

15. Renal Transplantation in the 90's Grand Rounds at the University of California at Irvine Medical Center, Irvine, California, October 6, 1994.

16. Renal Transplantation: Donor Selection and Postoperative Care. Ground Rounds of Mercy Hospital, San Diego, California, January 17, 1995.

17. Evaluating the 'Marginal' Living Donor. 14th Annual Advanced Nephrology Course: Nephrology for the Consultant, sponsored by the University of California, School of Medicine, San Diego, February 1995.

18. Organ Transplant - What the Generalist Can Learn from Organ Transplantation. 20th Annual Postgraduate Course: Topics and Advances in Internal Medicine, sponsored by the Department of Medicine, School of Medicine, University of California, San Diego, February 1995.

19. Drug Alert: Cytochrome p450 and Cyclosporine. 15th Annual Advanced Nephrology Course: Nephrology for the Consultant, sponsored by the University of California, School of Medicine, San Diego, February 1996.

20. Common Misperceptions in the Diagnosis and Management of Renal Disease. 21st Annual Postgraduate Course: Topics and Advances in Internal Medicine, sponsored by the Department of Medicine, School of Medicine, University of California, San Diego, February 1996.

21. "Management of Chronic Immunosuppression for the Renal Transplant Patient" presented at University of California at Irvine, November, 1996.

22. "Management of Chronic Immunosuppression for the Renal Transplant Patient" presented at University of Southern California Nephrology, February 1997.

23. Mini-Clinical Pathological Conference moderator at the 16th Annual Advanced Nephrology Course: Nephrology for the Consultant, sponsored by the University of California, School of Medicine, San Diego, February 1997.

24. "Drug Interaction and the Kidney: What Every Physician Needs to Know." Presented at Internal Medicine 1997, San Diego, March 1997.

25. "Approach to Acute and Chronic Renal Failure." Presented at Internal Medicine 1997, San Diego, March 1997.


19

26. "Emerging Strategies in Managing Chronic Transplant Immunosuppression." Presented at USC Medical Center, Nephrology Grand Rounds, Los Angeles, March 1997.

27. "Update on Chronic Immunosuppression in Renal Transplant Recipients." Presented at St. Joseph's Hospital, Orange, July 1997.

28. "Phosphate Wasting and Hyperparathyroidism in Renal Transplant Recipients." Presented at Hennepin County Medical Center, Minneapolis, August 1997.

29. "Kidney Transplantation." Presented at Mercy Hospital, San Diego, August 1997.

30. "Cyclosporine is Better Than FK506 for Transplant Immunosuppression." (Debate against Ron First, M.D.) Presented at Washington Hospital Center, Bethesda, February 1998.

31. “Peritoneal Dialysis for Acute Renal Failure.” Presented at the Third International Conference on Continuous Renal Replacement Therapies, San Diego, March, 1998.

32. “Doctor, Will I Get a Transplant This Year?” Presented at Advanced Nephrology: Nephrology for the Consultant, San Diego, 1999.

33. “The Long Term Management of the Renal Transplant Recipient.” Presented at Advanced Nephrology: Nephrology for the Consultant, San Diego, 1999.

34. Long Term Immunosuppression in the Renal transplant Patient. Presented at the Kaiser Permanente 1999 Nephrology Symposium, Pasadena, March 1999.

35. “Rational Transplant Immunosuppression.” Presented at UCLA-Harbor Medical Center, June 28, 1999.

36. Workshop B: Peritoneal and Home Dialysis - Prescription and Practice. Presented at Nephrology for the Consultant, San Diego, February 2001

37. Lessons from Cadaver Kidney Donors. Presented at Topics and Advances in Internal Medicine, San Diego, CA March, 2001.

38. “Management of Chronic Rejection.” Grand Rounds at Harbor-UCLA Medical Center, July, 2001.

39. “What Cadaver Donors Teach Us About Living Patients.” UNOS Region 5 Transplant Forum, San Diego, CA September, 2001.

40. “Renal Transplantation.” Grand Rounds for housestaff and students at UCSD Medical Center, November, 2001.

41. Recognition and Management of Electrolyte and Acid Base Disorders: A Case Based Approach. Seventh International Conference on Continuous renal Replacement Therapies, San Diego, March 2002.


20

42. Preparing the kidney transplant recipient and Risk factors in chronic transplant immunosuppression Topics in Internal Medicine UCSD course, March 12, 2003.

43. Obesity in Renal Transplant Recipients. Nephrology for the Consultant (UCSD national course), Coronado, California, February 6, 2003.

44. Chronic renal transplant management. Grand Rounds, California Pacific Medical Center, San Francisco, March 21, 2003

45. Invited speaker. “Chronic renal transplant management” Kaiser Permanente 6th Annual Nephrology Symposium, Anaheim California, May 5, 2003.

46. Invited speaker. “Ethical selection of living renal transplant donors” and “Medical risk factors in living kidney donors,” Vancouver Transplant Day, Vancouver BC, Canada, June 12, 2003.

47. “Management of Acute Renal Failure.” 27th Annual San Diego Postgraduate Assembly in Surgery.” Presented at First Annual Marshall J. Orloff Lecture. Wyndham Emerald Plaza. Hotel Conference Center, San Diego, CA, February 18, 2004.

48. “Electrolyte Management Hypokalemia, Hyperkalemia.” Presented at Topics and Advances in Internal Medicine. Catamaran Resort Hotel, San Diego, CA, February 19-25, 2004.

49. Invited Speaker. “The Current Status of Steroid Avoidance in Renal

Transplantation. What we Know so Far. The Con point of view.” Presented at Advanced Nephrology: Nephrology for the Consultant. Omni San Diego Hotel, San Diego, CA, February 10-12, 2005.

50. Invited Speaker. “Kidney Transplant Dilemmas.” Presented at Advanced Nephrology: Nephrology for the Consultant. Omni San Diego Hotel, San Diego, CA, February 10-12, 2005.

51. Invited Speaker. “Risk Estimation for Donor Candidates with Medical Abnormalities”. The Amsterdam Forum on the Care of the Live Kidney Donor. Amsterdam, Netherlands, April 1-4, 2004.

52. Invited Speaker. “Update on Organ Donation”. Physicians’ Luncheon, Paradise

Valley Hospital, San Diego, CA, October 20, 2005.

53. Invited Speaker. “Educating, Evaluating and Selecting Living Kidney Donors.” UCLA Kidney and Pancreas Transplantation Symposium, Los Angeles, CA, October 29, 2005.

54. Invited Speaker. “Balancing Risk and Patient Autonomy.” Enhancing Living Donation Forum

Canadian Council for Donation and Transplantation, February 10, 2006.


21

55. “Organ Donor Management,” Palomar Hospital Trauma Grand Rounds, March 23, 2006.

56. “Chronic Immunosuppression – Friend or Foe?” Presented at Advanced Nephrology: for the Consultant, La Jolla, CA, February, 22-24, 2007.

57. “Lessons From Beyond the Grave: What Deceased Donors Teach Us” Presented at Advanced Nephrology: for the Consultant, San Diego, 2007.

58. Debate Con “Preemptive Transplantation: Are We Over-Misunderestimating It?” Presented at Advanced Nephrology: for the Consultant, San Diego, 2007.


22

documentcv

Documents

san diego magazine

ca robert

abim university of california

american medical association

harvard medical school

university ofcalifornia

mercy hospital

cambridge hospital